An Act To Repeal Certain Maine Criminal Code Provisions Addressing So-called Bath Salts Containing Synthetic Hallucinogenic Drugs and Instead To Define Them as Schedule W Drugs
Maine Legislature, Session 126, LD 1439
Committee: Criminal Justice and Public Safety
Amends: 15 MRSA §5821, 17-A MRSA §1101, 17-A MRSA §1102, 17-A MRSA §1201, 22 MRSA §2383-B

Legislative Document 
No. 1439 
H.P. 1033 
House of Representatives, April 24, 2013 
An Act To Repeal Certain Maine Criminal Code Provisions 
Addressing So-called Bath Salts Containing Synthetic 
Hallucinogenic Drugs and Instead To Define Them as Schedule W 
Drugs 
Reported by Representative DION of Portland for the Criminal Law Advisory Commission 
pursuant to the Maine Revised Statutes, Title 17-A, section 1354, subsection 2. 
Reference to the Committee on Criminal Justice and Public Safety suggested and ordered 
printed pursuant to Joint Rule 218. 
MILLICENT M. MacFARLAND 
Clerk 
Be it enacted by the People of the State of Maine as follows: 
Sec. 1.  15 MRSA §5821, sub-§§1 and 2, as amended by PL 2011, c. 465, §1, are 
further amended to read: 
1.  Scheduled drugs.  All scheduled drugs and all synthetic hallucinogenic drugs, as 
defined in Title 17-A, section 1101, subsection 16-A, that have been manufactured, made, 
created, grown, cultivated, sold, bartered, traded, furnished for consideration, furnished, 
distributed, dispensed, possessed or otherwise acquired in violation of any law of this 
State, any other state or of the United States; 
2.  Materials related to scheduled drugs.  All raw materials, products and 
equipment of any kind that are used or intended for use in manufacturing, compounding, 
processing, delivering, cultivating, growing or otherwise creating any scheduled drug or 
any synthetic hallucinogenic drug, as defined in Title 17-A, section 1101, subsection 
16-A, in violation of any law of this State, any other state or the United States; 
Sec. 2.  15 MRSA §5821, sub-§3-A, as amended by PL 2011, c. 465, §2, is 
further amended to read: 
3-A.  Firearms and other weapons.  Law enforcement officers may seize all 
firearms and dangerous weapons that they may find in any lawful search for scheduled 
drugs or synthetic hallucinogenic drugs, as defined in Title 17-A, section 1101, 
subsection 16-A, in which scheduled drugs or synthetic hallucinogenic drugs are found.  
Except for those seized weapons listed in a petition filed in the Superior Court pursuant to 
section 5822, all weapons seized, after notice and opportunity for hearing, must be 
forfeited to the State by the District Court 90 days after a list of the weapons and drugs 
seized is filed in the District Court in the district in which the weapons and drugs were 
seized.  A weapon need not be forfeited if the owner appears prior to the declaration of 
forfeiture and satisfies the court, by a preponderance of evidence, of all of the following: 
A.  That the owner had a possessory interest in the weapon at the time of the seizure 
sufficient to exclude every person involved with the seized drugs or every person at 
the site of the seizure; 
B.  That the owner had no knowledge of or involvement with the drugs and was not 
at the site of the seizure; and 
C.  That the owner had not given any involved person permission to possess or use 
the weapon. 
Post-hearing procedures are as provided in section 5822.  
A confiscated or forfeited handgun that was confiscated or forfeited because it was used 
to commit a homicide must be destroyed by the State unless the handgun was stolen and 
the rightful owner was not the person who committed the homicide, in which case the 
handgun must be returned to the owner if ascertainable.  For purposes of this subsection, 
"handgun" means a firearm, including a pistol or revolver, designed to be fired by use of 
a single hand. 
Sec. 3.  15 MRSA §5821, sub-§6, as amended by PL 2011, c. 465, §3, is further 
amended to read: 
6.  Money instruments.  Except as provided in paragraph A, all money, negotiable 
instruments, securities or other things of value furnished or intended to be furnished by 
any person in exchange for a scheduled drug or synthetic hallucinogenic drug, as defined 
in Title 17-A, section 1101, subsection 16-A, in violation of Title 17-A, chapter 45; all 
proceeds traceable to such an exchange; and all money, negotiable instruments and 
securities used or intended to be used to facilitate any violation of Title 17-A, chapter 45. 
A.  No property may be forfeited under this subsection, to the extent of the interest of 
an owner, by reason of any act or omission established by that owner to have been 
committed or omitted without the knowledge or consent of that owner; 
Sec. 4.  15 MRSA §5821, sub-§7, as amended by PL 2011, c. 465, §4, is further 
amended to read: 
7.  Real property.  Except as provided in paragraph A, all real property, including 
any right, title or interest in the whole of any lot or tract of land and any appurtenances or 
improvements, that is used or intended for use, in any manner or part, to commit or to 
facilitate the commission of a violation of Title 17-A, section 1103, 1105-A, 1105-B, or 
1105-C, 1120, 1121 or 1123 that is a Class A, Class B or Class C crime, with the 
exception of offenses involving marijuana.  
A.  Property may not be forfeited under this subsection, to the extent of an interest of 
an owner, by reason of an act or omission established by that owner to have been 
committed or omitted without the knowledge or consent of that owner.  When an 
owner of property that is that person's primary residence proves by a preponderance 
of the evidence that the owner is the spouse or minor child of the coowner of the 
primary residence who has used or intended to use the residence, in any manner or 
part, to commit or facilitate the commission of a violation of Title 17-A, section 
1103, 1105-A, 1105-B, or 1105-C, 1120, 1121 or 1123, the State shall bear the 
burden of proving knowledge or consent of the spouse or minor child by a 
preponderance of the evidence; 
Sec. 5.  17-A MRSA §1101, sub-§16-A, as amended by PL 2011, c. 578, §§1 and 
2, is repealed. 
Sec. 6.  17-A MRSA §1102, sub-§1, ¶N, as amended by PL 2001, c. 419, §5, is 
further amended to read: 
N.    Flunitrazepam or its chemical equivalent; and 
Sec. 7.  17-A MRSA §1102, sub-§1, ¶O, as enacted by PL 2001, c. 419, §6, is 
amended to read: 
O.    Unless listed or described in another schedule, the following hallucinogenic 
drugs or their salts, isomers and salts of isomers whenever the existence of the salts, 
isomers and salts of isomers is possible within the chemical designation: 
 (1)  3, 4 - methylenedioxy amphetamine, MDA; 
 (2)  5  methoxy - 3, 4 methylenedioxy amphetamine, MMDA; 
 (3)  3, 4, 5 - trimethoxy amphetamine, TMA; 
 (4)  4 - methyl - 2, 5 - dimethoxyamphetamine, DOM; 
 (5)  2, - 3 methylenedioxyamphetamine; 
 (6)  2, 5 - dimethoxyamphetamine, DMA; 
 (7)  4 - bromo - 2, 5 - dimethoxyamphetamine, DOB; 
 (8)  4 methoxyamphetamine; 
 (9)  3, 4 - methylenedioxymethamphetamine, MDMA; 
 (10)  4 - bromo - 2, 5 - dimethoxyphenethylamine, NEXUS; 
 (11)  3, 4 - methylenedioxy-N-ethylamphetamine, MDE; 
 (12)  Paramethoxymethamphetamine, PMMA; 
 (13)  Paramethoxyamphetamine, PMA; and 
 (14)  Paramethoxyethylamphetamine, PMEA.; and 
Sec. 8.  17-A MRSA §1102, sub-§1, ¶P is enacted to read: 
P.  Unless listed or described in another schedule, the following synthetic 
hallucinogenic drugs: 
(1)  3, 4 - methylenedioxymethcathinone, MDMC; 
(2)  3, 4 - methylenedioxypyrovalerone, MDPV; 
(3)  4 - methylmethcathinone, 4-MMC; 
(4)  4 - methoxymethcathinone, bk-PMMA, PMMC; 
(5)  3 - fluoromethcathinone, FMC; 
(6)  4 - fluoromethcathinone, FMC; 
(7)  Napthylpyrovalerone, NRG-1; 
(8)  Beta-keto-N-methylbenzodioxolylpropylamine; 
(9)  4 - methylethcathinone, 4-MEC; 
(10)  Butylone; 
(11)  Eutylone; 
(12)  Pentedrone; 
(13)  Pentylone; 
(14)  2, 5 - dimethoxy-4-ethylphenethylamine; or 
(15)  A derivative of cathinone, including any compound, material, mixture, 
preparation or other product, structurally derived from 2-aminopropan-1-one by 
substitution at the 1-position with either phenyl, naphthyl or thiophene ring 
systems, whether or not the compound is further modified in any of the following 
ways: 
(a) By substitution in the ring system to any extent with alkyl, alkylenedioxy, 
alkoxy, haloalkyl, hydroxyl or halide substituents, whether or not further 
substituted in the ring system by one or more other univalent substituents; 
(b) By substitution at the 3-position with an acyclic alkyl substituent; or 
(c) By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl or 
methoxybenzyl groups or by inclusion of the 2-amino nitrogen atom in a 
cyclic structure. 
This subparagraph does not include a drug listed in section 1102 or a drug 
approved by the United States Food and Drug Administration. 
Sec. 9.  17-A MRSA §1102, sub-§5, as enacted by PL 1975, c. 499, §1, is 
repealed. 
Sec. 10.  17-A MRSA §§1119 to 1123, as enacted by PL 2011, c. 465, §6, are 
repealed. 
Sec. 11.  17-A MRSA §1201, sub-§1, ¶A-1, as amended by PL 2011, c. 640, Pt. 
B, §7, is further amended to read: 
A-1.  The conviction is for a Class D or Class E crime other than: 
(1)  A Class D or Class E crime relative to which, based upon both the written 
agreement of the parties and a court finding, the facts and circumstances of the 
underlying criminal episode giving rise to the conviction generated probable 
cause to believe the defendant had committed a Class A, Class B or Class C 
crime in the course of that criminal episode and, as agreed upon in writing by the 
parties and found by the court, the defendant has no prior conviction for murder 
or for a Class A, Class B or Class C crime and has not been placed on probation 
pursuant to this subparagraph on any prior occasion; 
(2)  A Class D crime that the State pleads and proves was committed against a 
family or household member or a dating partner under chapter 9 or 13 or section 
554, 555 or 758.  As used in this subparagraph, "family or household member" 
has the same meaning as in Title 19-A, section 4002, subsection 4; "dating 
partner" has the same meaning as in Title 19-A, section 4002, subsection 3-A;  
(2-A)  A Class D crime under Title 5, section 4659,  subsection 1, Title 15, 
section 321, subsection 6 or Title 19-A, section 4011, subsection 1; 
(3)  A Class D or Class E crime in chapter 11 or 12; 
(4)  A Class D crime under section 210-A; 
(4-A)  A Class E crime under section 552; 
(5)  A Class D or Class E crime under section 556, section 854, excluding 
subsection 1, paragraph A, subparagraph (1), or section 855; 
(6)  A Class D crime in chapter 45 relating to a schedule W drug;  
(7)  A Class D or Class E crime under Title 29-A, section 2411, subsection 1-A, 
paragraph B;  
(8)  A Class D crime under Title 17, section 1031; or 
(9) A Class D crime under Title 17-A, section 1119, subsection 1; or 
(10)  A Class E crime under Title 15, section 1092, subsection 1, paragraph A, if 
the condition of release violated is specified in Title 15, section 1026, subsection 
3, paragraph A, subparagraph (5) or (8) and the underlying crime involved 
domestic violence. 
Sec. 12.  22 MRSA §2383-B, sub-§2-A, as enacted by PL 2011, c. 465, §8, is 
repealed. 
Sec. 13.  22 MRSA §2383-B, sub-§3, ¶D-1, as enacted by PL 2011, c. 465, §9, is 
repealed. 
Sec. 14.  Maine Revised Statutes headnote amended; revision clause.  In 
the Maine Revised Statutes, Title 22, chapter 558, in the chapter headnote, the words 
"marijuana, scheduled drugs, imitation scheduled drugs, certain synthetic hallucinogenic 
drugs and hypodermic apparatuses" are amended to read "marijuana, scheduled drugs, 
imitation scheduled drugs and hypodermic apparatuses" and the Revisor of Statutes shall 
implement this revision when updating, publishing or republishing the statutes. 
SUMMARY 
This bill is proposed by the Criminal Law Advisory Commission.  The bill repeals 
provisions criminalizing synthetic hallucinogenic drugs in chapter 45 of the Maine 
Criminal Code and in related provisions regarding asset forfeiture in the Maine Revised 
Statutes, Title 15 and regarding drug-related offenses in Title 22 and instead classifies 
these drugs as schedule W drugs.  As schedule W drugs, they are treated the same as all 
other schedule W drugs for purposes of possession, trafficking and furnishing. 
The bill also repeals an unnecessary provision of law that prohibits including a drug 
or substance in schedule W, X, Y or Z that is legally sold in the State without any federal 
or state requirements as to prescription and that is unaltered as to its form.